Regulation of Mitochondrial Morphology by Positive Feedback Interaction Between PKCδ and Drp1 in Vascular Smooth Muscle Cell
Authors:
- 16 November 2014
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 116 (4) , 648-660
Abstract
Dynamin‐related protein‐1 (Drp1) plays a critical role in mitochondrial fission which allows cell proliferation and Mdivi‐1, a specific small molecule Drp1 inhibitor, is revealed to attenuate proliferation. However, few molecular mechanisms‐related to Drp1 under stimulus for restenosis or atherosclerosis have been investigated in vascular smooth muscle cells (vSMCs). Therefore, we hypothesized that Drp1 inhibition can prevent vascular restenosis and investigated its regulatory mechanism. Angiotensin II (Ang II) or hydrogen peroxide (H2O2)‐induced proliferation and migration in SMCs were attenuated by down‐regulation of Drp1 Ser 616 phosphorylation, which was demonstrated by in vitro assays for migration and proliferation. Excessive amounts of ROS production and changes in mitochondrial membrane potential were prevented by Drp1 inhibition under Ang II and H2O2. Under the Ang II stimulation, activated Drp1 interacted with PKCδ and then activated MEK1/2‐ERK1/2 signaling cascade and MMP2, but not MMP9. Furthermore, in ex vivo aortic ring assay, inhibition of the Drp1 had significant anti‐proliferative and ‐migration effects for vSMCs. A formation of vascular neointima in response to a rat carotid artery balloon injury was prevented by Drp1 inhibition, which shows a beneficial effect of Drp1 regulation in the pathologic vascular condition. Drp1‐mediated SMC proliferation and migration can be prevented by mitochondrial division inhibitor (Mdivi‐1) in in vitro, ex vivo and in vivo, and these results suggest the possibility that Drp1 can be a new therapeutic target for restenosis or atherosclerosis. J. Cell. Biochem. 116: 648–660, 2015.Keywords
Funding Information
- Korea Science and Engineering Foundation Grant funded by the Korean Government (MEST) (2014030459)
- Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A120478)
- Yonsei University College of Medicine for 2013 (2013-32-0051)
- Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea (HI08C2149)
This publication has 44 references indexed in Scilit:
- Attenuation of Doxorubicin-Induced Cardiotoxicity by mdivi-1: A Mitochondrial Division/Mitophagy InhibitorPLOS ONE, 2013
- Dynamin-Related Protein 1–Mediated Mitochondrial Mitotic Fission Permits Hyperproliferation of Vascular Smooth Muscle Cells and Offers a Novel Therapeutic Target in Pulmonary HypertensionCirculation Research, 2012
- Mitochondrial division/mitophagy inhibitor (Mdivi) Ameliorates Pressure Overload Induced Heart FailurePLOS ONE, 2012
- Inhibition of mitochondrial fission prevents cell cycle progression in lung cancerThe FASEB Journal, 2012
- Aberrant mitochondrial fission in neurons induced by protein kinase Cδ under oxidative stress conditions in vivoMolecular Biology of the Cell, 2011
- Different Effects of Angiotensin II and Angiotensin-(1-7) on Vascular Smooth Muscle Cell Proliferation and MigrationPLOS ONE, 2010
- Calcific Aortic StenosisArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Mitochondrial dynamics and apoptosisGenes & Development, 2008
- Mitochondrial fission mediates high glucose-induced cell death through elevated production of reactive oxygen speciesCardiovascular Research, 2008
- Protein kinase C-δ regulates migration and proliferation of vascular smooth muscle cells through the extracellular signal-regulated kinase 1/2Journal of Vascular Surgery, 2007